Continuous Subcutaneous Insulin Infusions vs. Multiple Daily Injections of Insulin in Hospitalized Patients: Glycemic Trends in the First 24 Hours of Admission.
Amanda HalstromIram MoledinaVirginia Peragallo-DittkoKarena AnconaShahidul IslamStanislaw KlekGary D RothbergerPublished in: Journal of diabetes science and technology (2021)
Patients using CSII experienced fewer events of both hypoglycemia and hyperglycemia in the first 24 hours of hospital admission than those treated with MDI. Our study demonstrates that CSII use is safe and effective for the treatment of diabetes within the first 24 hours of hospital admission.
Keyphrases
- type diabetes
- glycemic control
- emergency department
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- cardiovascular disease
- ejection fraction
- peritoneal dialysis
- adverse drug
- acute care
- insulin resistance
- patient reported outcomes
- skeletal muscle
- platelet rich plasma
- adipose tissue
- diabetic rats
- electronic health record